Very different results and very different timelines
Clinical data shows semaglutide achieves HbA1c reductions of up to 1.7%2.0%, with weight loss exceeding 10% body mass in nearly 45%61% of patients, significantly outperforming earlier therapies
AOD 9604 With Retatrutide: Evidence, Safety, and UK Regulatory Status AOD 9604 with retatrutide is a combination increasingly discussed in weight-loss and body-composition circles, yet neither compound holds a Marketing Authorisation from the MHRA or EMA for use in the UK
Additionally, the specific formulation mattersoral semaglutide may take 4 to 8 weeks to show the same appetite suppression as injectable forms because it has lower bioavailability, whereas PlexusDx's compounded semaglutide injection ($189/mo) delivers direct systemic absorption within hours
While many people benefit from them, some experience gastrointestinal side effects, and rare but serious complications such as bowel obstruction, gallbladder disease, gastroparesis, pancreatitis, kidney problems, and thyroid tumors have been reported